Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 0 | 0 | 0 | 2,000 | 0 |
| Cost of Goods | N/A | N/A | N/A | 254 | N/A |
| Gross Profit | N/A | N/A | N/A | 1,746 | N/A |
| Operating Expenses | 789 | 358 | 633 | 660 | 530 |
| Operating Income | -789 | -358 | -633 | 1,340 | -530 |
| Other Income | -63 | -69 | -60 | -62 | -60 |
| Pre-tax Income | -852 | -427 | -693 | 1,278 | -590 |
| Income Tax | 3 | -49 | N/A | N/A | -3 |
| Net Income Continuous | -855 | -378 | -693 | 1,278 | -587 |
| Net Income | $-855 | $-378 | $-693 | $1,278 | $-587 |
| EPS Basic Total Ops | -20.00 | -10.00 | -10.00 | 20.00 | -10.00 |
| EPS Basic Continuous Ops | -15.72 | -6.95 | -12.74 | 23.50 | -10.79 |
| EPS Diluted Total Ops | -20.00 | -10.00 | -10.00 | 20.00 | -10.00 |
| EPS Diluted Continuous Ops | -15.72 | -6.95 | -12.74 | 23.50 | -10.79 |
| EBITDA(a) | $-750 | $-319 | $-593 | $1,379 | $-491 |